Related Experiment Videos
Optimization of "Askoeziuofito" tablets
Arūnas Savickas1, Jurga Bernatoniene
1Department of Drug Technology and Social Pharmacy, Kaunas University of Medicine, A. Mickeviciaus 9, 44307 Kaunas, Lithuania.
Medicina (Kaunas, Lithuania)
|April 14, 2005
Summary
This study optimized tablet excipient levels to improve tablet strength, abrasion resistance, and drug release rates. Mathematical planning ensured optimal formulation for consistent tablet quality and performance.
Area of Science:
- Pharmaceutical Technology
- Materials Science
Background:
- Tablet formulation requires careful selection of excipients to achieve desired technological properties.
- Optimizing excipient levels is crucial for tablet quality, including mechanical strength and drug release.
Purpose of the Study:
- To experimentally determine optimal limits for excipients (silica colloidal anhydrous, magnesium stearate, potato starch, saccharose).
- To evaluate the impact of these excipients on tablet sticking, crushing strength, abrasion resistance, and drug release speed.
Main Methods:
- Technological parameters assessed: mean mass, crushing strength, abrasion resistance, disintegration time, and release rate of ascorbic and chicoric acids.
- Active substances identified and quantified using chromatography (HPLC, TLC) and spectrophotometry.
- Mathematical planning techniques (fractional factorial design, steepest ascent, orthogonal compositional design) employed for optimization.
Main Results:
- Optimal excipient amounts were identified using mathematical planning.
- These optimized formulations resulted in improved tablet crushing strength, abrasion resistance, and controlled drug release.
- Developed and validated analytical methods for active substances in tablets and performed stability tests.
Conclusions:
- Mathematical planning is effective for optimizing tablet formulations.
- Optimized excipient levels ensure desired tablet quality attributes and predictable drug release profiles.
- Established analytical and stability testing protocols for pharmaceutical preparations.